Evotec SE (EVO) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Evotec SE Revenue Highlights


Latest Revenue (Y)

$781.43M

Latest Revenue (Q)

$208.73M

Evotec SE Revenue by Period


Evotec SE Revenue by Year

DateRevenueChange
2023-12-31$781.43M3.99%
2022-12-31$751.45M21.59%
2021-12-31$618.03M23.38%
2020-12-31$500.92M12.20%
2019-12-31$446.44M18.92%
2018-12-31$375.40M45.71%
2017-12-31$257.63M56.61%
2016-12-31$164.51M28.85%
2015-12-31$127.68M42.66%
2014-12-31$89.50M4.14%
2013-12-31$85.94M-1.52%
2012-12-31$87.27M8.91%
2011-12-31$80.13M45.00%
2010-12-31$55.26M29.47%
2009-12-31$42.68M7.75%
2008-12-31$39.61M20.46%
2007-12-31$32.88M-51.18%
2006-12-31$67.35M5.05%
2005-12-31$64.11M3211.02%
2004-12-31$1.94M-45.81%
2003-12-31$3.57M100.00%
2002-12-31-100.00%
2001-12-31--

Evotec SE generated $781.43M in revenue during NA 2023, up 3.99% compared to the previous quarter, and up 208.16% compared to the same period a year ago.

Evotec SE Revenue by Quarter

DateRevenueChange
2024-03-31$208.73M3.68%
2023-12-31$201.31M2.57%
2023-09-30$196.28M15.27%
2023-06-30$170.28M-11.27%
2023-03-31$191.92M-20.26%
2022-12-31$240.69M38.42%
2022-09-30$173.88M0.98%
2022-06-30$172.20M4.57%
2022-03-31$164.67M-11.97%
2021-12-31$187.07M17.17%
2021-09-30$159.66M15.51%
2021-06-30$138.22M3.86%
2021-03-31$133.09M-5.28%
2020-12-31$140.51M8.56%
2020-09-30$129.43M15.99%
2020-06-30$111.59M-6.55%
2020-03-31$119.40M-4.54%
2019-12-31$125.08M9.45%
2019-09-30$114.27M10.69%
2019-06-30$103.24M-0.59%
2019-03-31$103.85M-1.46%
2018-12-31$105.39M9.48%
2018-09-30$96.26M1.57%
2018-06-30$94.77M19.99%
2018-03-31$78.98M-8.98%
2017-12-31$86.78M28.64%
2017-09-30$67.46M26.77%
2017-06-30$53.21M6.03%
2017-03-31$50.18M14.37%
2016-12-31$43.88M-2.86%
2016-09-30$45.17M18.95%
2016-06-30$37.98M1.32%
2016-03-31$37.48M-5.07%
2015-12-31$39.48M18.77%
2015-09-30$33.24M-0.53%
2015-06-30$33.42M55.12%
2015-03-31$21.54M-29.52%
2014-12-31$30.56M62.16%
2014-09-30$18.85M-16.13%
2014-06-30$22.47M27.61%
2014-03-31$17.61M-31.26%
2013-12-31$25.62M8.41%
2013-09-30$23.63M20.40%
2013-06-30$19.63M15.01%
2013-03-31$17.06M-26.01%
2012-12-31$23.06M4.10%
2012-09-30$22.16M1.00%
2012-06-30$21.94M9.08%
2012-03-31$20.11M-1.50%
2011-12-31$20.42M-22.51%
2011-09-30$26.35M44.30%
2011-06-30$18.26M20.87%
2011-03-31$15.11M-8.01%
2010-12-31$16.42M18.38%
2010-09-30$13.87M-8.30%
2010-06-30$15.13M53.71%
2010-03-31$9.84M-27.36%
2009-12-31$13.55M30.32%
2009-09-30$10.40M-1.00%
2009-06-30$10.50M27.47%
2009-03-31$8.24M-42.95%
2008-12-31$14.44M35.49%
2008-09-30$10.66M47.85%
2008-06-30$7.21M-1.43%
2008-03-31$7.31M-24.85%
2007-12-31$9.73M-

Evotec SE generated $208.73M in revenue during Q1 2024, up 3.68% compared to the previous quarter, and up 86.72% compared to the same period a year ago.

Evotec SE Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
RDYDr. Reddy's Laboratories$279.16B-
NBIXNeurocrine Biosciences$1.89B$590.20M
PBHPrestige Consumer Healthcare$1.13B$267.14M
PAHCPhibro Animal Health$977.89M$263.22M
EVOEvotec SE$781.43M$208.73M
PCRXPacira BioSciences$674.98M$178.02M
SUPNSupernus Pharmaceuticals$607.52M$168.32M
COLLCollegium Pharmaceutical$566.77M$144.92M
ANIPANI Pharmaceuticals$486.82M$138.04M
EGRXEagle Pharmaceuticals$316.61M$64.65M
DCPHDeciphera Pharmaceuticals$163.36M$45.00M
SSICSilver Spike Investment$11.72M$2.76B
RGCRegencell Bioscience--

EVO Revenue FAQ


Evotec SE's yearly revenue for 2023 was $781.43M, representing an increase of 3.99% compared to 2022. The company's yearly revenue for 2022 was $751.45M, representing an increase of 21.59% compared to 2021. EVO's yearly revenue for 2021 was $618.03M, representing an increase of 23.38% compared to 2020.

Evotec SE's quarterly revenue for Q1 2024 was $208.73M, a 3.68% increase from the previous quarter (Q4 2023), and a 8.76% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $201.31M, a 2.57% increase from the previous quarter (Q3 2023), and a -16.36% decrease year-over-year (Q4 2022). EVO's quarterly revenue for Q3 2023 was $196.28M, a 15.27% increase from the previous quarter (Q2 2023), and a 12.88% increase year-over-year (Q3 2022).

Evotec SE's revenue growth rate for the last 3 years (2021-2023) was 26.44%, and for the last 5 years (2019-2023) was 75.04%.